MedTrace Logo

Magnesium Sulphate Injection in Treatment of Myofascial Trigger Points

NCT04742140 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2021-12-07

No results posted yet for this study

Summary

This is a prospective, single- center, randomized (1:1) clinical trial comparing the effectiveness of magnesium sulphate injections in treatment of myofascial trigger points in the masseter muscle versus the saline injection.

Conditions

  • Trigger Point Pain, Myofascial

Interventions

DRUG

Magnesium sulfate

each patient injected 0.5ml in each TrPs of magnesium sulphate according to the treatment group by the same operator

DRUG

Saline

each patient injected 0.5ml in each TrPs of saline according to the treatment group by the same operator

Sponsors & Collaborators

  • Fayoum University

    lead OTHER

Principal Investigators

  • Alshaimaa Mohamed, phd · Fayoum University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-20
Primary Completion
2021-08-20
Completion
2021-09-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04742140 on ClinicalTrials.gov